Federal US government funding of $354m has been awarded to domestic start-up firm Phlow Corp for “advanced manufacturing of America’s most essential medicines at risk of shortage,” including in particular medicines needed for country’s response to the COVID-19 pandemic.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?